Pelpod 100 DT Tablet Delicious Orange
By Pelpod
Rx
10 Tablet DT in a Strip

Composition
Cefpodoxime Proxetil(100mg)

Manufacturer - Pelzar Healthcare
301, Sahaj Residency, Near Vadaj Bus Stop Vadaj, Ahmedabad-380013, Gujarat, India

Expires on or after
October, 2025

liver
Pelpod 100 DT Tablet Delicious Orange is considered safe for use in individuals with liver disease. It is reassuring to note that no dose adjustment for Pelpod 100 DT Tablet Delicious Orange is necessary in such cases. This suggests that the medication does not have a significant impact on liver function and can be used safely by individuals with liver issues. It is always advisable to consult with your healthcare provider for personalized guidance on using Pelpod 100 DT Tablet Delicious Orange if you have any concerns about liver health.

kidney
Caution Pelpod 100 DT Tablet Delicious Orange requires caution in severe kidney disease. Adjusting the dose may be necessary. Consult your doctor before use.

alcohol
When taking Pelpod 100 DT Tablet Delicious Orange, it is safe to consume alcohol as it does not lead to any harmful side effects.

driving
Pelpod 100 DT Tablet Delicious Orange may cause drowsiness, reduced alertness, or vision changes. Avoid driving if you experience these effects.

pregnancy
Pelpod 100 DT Tablet Delicious Orange is generally safe to use during pregnancy based on animal studies, but limited human studies are available.

breastfeeding
Pelpod 100 DT Tablet Delicious Orange is safe to use during breastfeeding. Studies show that it does not pass into breastmilk in significant amounts, making it safe for the baby. However, avoid prolonged use to prevent possible side effects like rash and diarrhea.
Habit Forming | No |
Chemical Class | Broad Spectrum (Third & fourth generation cephalosporins) |
Therapeutic Class | ANTI INFECTIVES |
Action Class | Cephalosporins: 3 generation |
₹99
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025